金币
UID176556
帖子
主题
积分25326
注册时间2014-6-6
最后登录1970-1-1
听众
性别保密
|
欢迎您注册蒲公英
您需要 登录 才可以下载或查看,没有帐号?立即注册
x
产品质量受权人放行前必须由QC负责人(检验部分)批准??是否有要求QA负责人批准??
9.14 The authorized person responsible for approving a batch for release should always ensure that the following requirements have been met:
(a) the marketing authorization and the manufacturing authorization requirements for the product have been met for the batch concerned;
(b) the principles and guidelines of GMP, as laid down in the guidelines published by WHO, have been followed;
(c) the principal manufacturing and testing processes have been validated;
(d) all the necessary checks and tests have been performed and account taken of the production conditions and manufacturing records;
(e) any planned changes or deviations in manufacturing or QC have been notified in accordance with a well-defined reporting system before any product is released. Such changes may need notification to, and approval by, the medicines regulatory authority;
(f ) any additional sampling, inspection, tests and checks have been carried out or initiated, as appropriate, to cover planned changes and deviations;
(g) all necessary production and QC documentation has been completed and endorsed by supervisors trained in appropriate disciplines;
(h) appropriate audits, self-inspections and spot-checks are carried out by experienced and trained staff;
(i) approval has been given by the head of QC;
(j) all relevant factors have been considered, including any not specifically associated with the output batch directly under review (e.g. subdivision of output batches from a common input, factors associated with continuous production runs).
选自WHO GMP
|
|